Kindeva Drug Delivery

Day two of the Drug Delivery to the Lungs (#DDL) Conference is almost over! It's been a pleasure meeting so many of you already. Are you ready to bring your therapy to the world? Visit us at booth #430 or schedule a meeting here: loom.ly/KEWljzc [loom.ly]

HFA152a is a promising #greenpropellant option with the potential to reduce the environmental impact of #pMDIs without compromising patient care. In this white paper published with @FiercePharma, we share considerations for a smoother transition. fp-resources.fiercepharma.com/free/w_defa733…

From low-GWP propellant characteristics to nasal #drugdelivery, Kindeva’s team will share their expertise on a broad range of topics at #DDL2024. Stop by our poster presentations for your inside look at our latest developments and insights. ow.ly/FsKS50TYsvI

We are a leading #inhalation drug delivery #CDMO, with a full range of capabilities and unrivaled know-how. Watch this video featuring our Vice President, MDI Business Development, Andy Burns, to dive deeper into the benefits of combining forces. #pulmonary-nasal-platform-technologies" target="_blank" rel="nofollow noopener">kindevadd.com/pulmonary-nasa…

If you are looking for a #CDMO that is built for the future, with capacity ready now, #combineforces with Kindeva. At CPHI, we showcased our Annex 1 compliant facility, our green propellant lines, and much more. Contact us to explore our capabilities. kindevadd.com/events/cphi-wo…

If you did not have a chance to attend our recent webinar live, you can still hear our experts’ thoughts on intradermal #drugdelivery, from development challenges to strategies for commercialization. Visit our website to download the replay. kindevadd.com/library/charac…

Kindeva has helped protect civilians, military service members, and first responders around the world for more than 60 years. Interested in exploring our global health security capabilities? These are two upcoming opportunities to connect with us. #ghs-events" target="_blank" rel="nofollow noopener">kindevadd.com/events/#ghs-ev…

Are you prepared to meet the FDA’s latest guidelines for device design outputs? In this presentation, our Vice President of Analytical Services, Jennifer Riter, will share her expert insights for establishing and assessing drug delivery performance.pharmaedresources.com/event/pre-fill…

Our aseptic #injectable fill-finish capacity is ready when you are. At #CPHIWorldwide, Kindeva offered an inside look at our Annex 1 compliant facility in Bridgeton, MO. Visit our website for your chance to explore our world-class capabilities. youtu.be/h7CosnYE50Y?si…

Kindeva delivers unrivaled expertise in respiratory delivery, backed by over 65 years of experience. This video covers our key innovations over the years and our future-forward initiatives. ow.ly/jWYy50T834W #Inhalation #Drugdelivery #CombineForces

Epithelial delivery has the potential to provide far-reaching benefits, as John Patton explains in this snippet from his presentation on respiratory and microneedle vaccination. Visit our website to download the full presentation. kindevadd.com/library/elimin… #vaccinedevelopment

Kindeva leads the way in sterile injectable fill-finish. FAT is complete for our Optima isolated filling line, which is currently on its way to our Bridgeton, MO, facility. Learn more about this partnership on our website and stay tuned for more updates. kindevadd.com/aseptic-inject…

Tech transfer presents various challenges, from documentation to regulatory requirements and beyond. In this article, Kindeva’s Director, Client Portfolio & Relationship Management, Kimberly Brown, shares her insights on overcoming these hurdles. linkedin.com/pulse/addressi…

Kindeva is an industry leader in respiratory #drugdelivery. From our invention of the #pMDI to becoming the first #CDMO with low-GWP propellant capabilities, we are built for the future. Discover how we can accelerate your timeline at #DDL2024. ow.ly/wmv950TYsgf

11.7 million people in America live with chronic obstructive pulmonary disease (#COPD), according to the American Lung Association. Kindeva supports those with COPD through our pulmonary platforms. We hope you will join us in spreading awareness this month.

Sustainability is driving a transition to green pMDI propellants, and HFA152a is one of the most promising options. Download our white paper for an overview of its benefits and learn how partnering with a CDMO with HFA152a capabilities could benefit you. kindevadd.com/library/hfa152…

Our intradermal webinar, hosted through Xtalks, is starting soon. Tune in for an in-depth discussion of recent developments in microneedle array patch technology, plus the opportunity to pose your questions to our panel. ow.ly/tPQr50TEf1f

Have you registered for our webinar? There is still time to save your spot for the opportunity to hear from our panel of intradermal experts. The webinar will also feature a live Q&A, so do not miss this opportunity to ask your microneedle questions. ow.ly/mB2u50TEeKh

Our fully Annex 1 compliant facility in Bridgeton, MO, features state-of-the-art technology, including four isolated filling lines and utilities sized for eight. Take a virtual tour of our site in this video walkthrough. youtu.be/EVJLYw9uk7w #sterilefillfinish  #CombineForces

With Kindeva, manufacturing more tomorrows starts today. Our capabilities address the most pressing concerns for respiratory #drugdelivery, while evolving with a constant eye toward the future. Visit our website to explore our capabilities. youtu.be/ittADwmk8I0?si…